Pfizer and BioNTech will soon ask the FDA to authorize the use of their vaccines for children over the age of 5.
The New York Times reported that company officials will be giving data from vaccine trials to the FDA in the coming weeks and will ask that the emergency use authorization be expanded to include this age group.